2,4-pyridinedicarboxylic acid has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimori, DG; Gileadi, C; Gregori-Puigjané, E; Iwasa, E; Korczynska, M; Krojer, T; Le, DD; Nowak, RP; Oppermann, U; Ortiz Torres, I; Pollock, SB; Shoichet, BK; Tumber, A; Velupillai, S; Younger, N | 1 |
| Chang, J; Liu, HM; Pang, JR; Ren, HM; Wang, LC; Zheng, YC | 1 |
| Brewitz, L; McDonough, MA; Pfeffer, I; Schofield, CJ; Tumber, A | 1 |
1 review(s) available for 2,4-pyridinedicarboxylic acid and Benign Neoplasms
| Article | Year |
|---|---|
Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target.
Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Jumonji Domain-Containing Histone Demethylases; Molecular Structure; Neoplasms; Nuclear Proteins; Repressor Proteins; Structure-Activity Relationship | 2019 |
2 other study(ies) available for 2,4-pyridinedicarboxylic acid and Benign Neoplasms
| Article | Year |
|---|---|
Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors.
Topics: Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Humans; Jumonji Domain-Containing Histone Demethylases; Mesalamine; Molecular Docking Simulation; Neoplasms; Small Molecule Libraries | 2016 |
Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Crystallography, X-Ray; Drug Discovery; Drug Screening Assays, Antitumor; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Hydroxylation; Mass Spectrometry; Mixed Function Oxygenases; Neoplasms; Pyridines | 2020 |